.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Serving 500+ biopharmaceutical companies globally:

McKesson
Dow
Accenture
Argus Health
AstraZeneca
Boehringer Ingelheim
Medtronic
QuintilesIMS
Farmers Insurance
Chubb

Most drug patent challenges last year

This chart shows the generic firms that had the most successful drug patent challenges last year.

Companies that successfully challenge patents on branded drugs are granted six months of generic exclusivity. And, because first-to-market generics tend to sell at 70% or more of the price of the branded drug, the financial rewards stemming from the market exclusivity granted for drug patent challenges can more than cover the subtantial costs of drug patent challenge and associated litigation.

The most successful patent challengers in 2016 were

Back to Pharmaceutical Industry Infographics

For more information try a trial or see the database preview and plans and pricing

botpot